Huaidong Cheng Selected Research

Chemotherapy-Related Cognitive Impairment

1/2022	The COMT Genetic Factor Regulates Chemotherapy-Related Prospective Memory Impairment in Survivors With HER2-/+ Breast Cancer.
1/2021	Changes in cytokine levels in breast cancer patients with CRCI before or after CALM intervention.
1/2020	Changes in plasma IL-1β, TNF-α and IL-4 levels are involved in chemotherapy-related cognitive impairment in early-stage breast cancer patients.
1/2019	The dorsolateral prefrontal cortex is selectively involved in chemotherapy-related cognitive impairment in breast cancer patients with different hormone receptor expression.
1/2016	The COMT (rs165599) gene polymorphism contributes to chemotherapy-induced cognitive impairment in breast cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huaidong Cheng Research Topics

Disease

18	Breast Neoplasms (Breast Cancer) 01/2022 - 10/2013
12	Neoplasms (Cancer) 08/2022 - 01/2017
5	Chemotherapy-Related Cognitive Impairment 01/2022 - 01/2016
4	Cognitive Dysfunction 01/2022 - 01/2018
2	Fatigue 01/2022 - 01/2017
1	Hepatocellular Carcinoma (Hepatoma) 08/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Esophageal Squamous Cell Carcinoma 01/2021
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Esophageal Neoplasms (Esophageal Cancer) 01/2021
1	Melanoma (Melanoma, Malignant) 10/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Carcinogenesis 01/2019
1	Brain Neoplasms (Brain Tumor) 10/2018
1	Nasopharyngeal Carcinoma 01/2018
1	Neutropenia 01/2017
1	Hypersensitivity (Allergy) 01/2017
1	Vomiting 01/2017
1	Nausea 01/2017
1	Triple Negative Breast Neoplasms 01/2016

Drug/Important Bio-Agent (IBA)

3	CytokinesIBA 01/2022 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 08/2022 - 10/2020
2	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2022 - 09/2020
2	Interleukin-4 (Interleukin 4)IBA 01/2021 - 01/2020
2	Apolipoproteins E (ApoE)IBA 09/2020 - 01/2016
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 09/2020 - 01/2016
2	Progesterone Receptors (Progesterone Receptor)IBA 09/2020 - 03/2017
2	Estrogen ReceptorsIBA 09/2020 - 03/2017
2	ApolipoproteinsIBA 09/2020 - 01/2016
2	Hormones (Hormone)IBA 01/2019 - 03/2017
1	Messenger RNA (mRNA)IBA 08/2022
1	AldehydesIBA 08/2022
1	Oxidoreductases (Dehydrogenase)IBA 08/2022
1	human ERBB2 proteinIBA 01/2022
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Genetic Markers (Genetic Marker)IBA 09/2020
1	acceleratory factor from growth hormone (AcG)IBA 01/2020
1	apatinibIBA 01/2020
1	Lysine (L-Lysine)FDA Link 01/2019
1	ProteomeIBA 01/2019
1	Hemoglobins (Hemoglobin)IBA 01/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017
1	Docetaxel (Taxotere)FDA Link 01/2017
1	IGF-I-IGFBP-3 complex FDA Link 01/2017
1	catechol (pyrocatechol)IBA 01/2016
1	TransferasesIBA 01/2016

Therapy/Procedure

14	Drug Therapy (Chemotherapy) 01/2022 - 10/2013
5	Therapeutics 01/2022 - 01/2018
3	Radiotherapy 01/2021 - 01/2018
3	Adjuvant Chemotherapy 03/2017 - 10/2013
2	Immunotherapy 01/2022 - 01/2022
1	Smart Glasses 01/2019
1	Neoadjuvant Therapy 01/2017